These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18281290)

  • 21. A role of the sulfonylurea receptor 1 in endocytic trafficking of ATP-sensitive potassium channels.
    Bruederle CE; Gay J; Shyng SL
    Traffic; 2011 Sep; 12(9):1242-56. PubMed ID: 21649805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor.
    Reimann F; Tucker SJ; Proks P; Ashcroft FM
    J Physiol; 1999 Jul; 518 ( Pt 2)(Pt 2):325-36. PubMed ID: 10381582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
    Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
    Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian steroids stimulate adenosine triphosphate-sensitive potassium (KATP) channel subunit gene expression and confer responsiveness of the gonadotropin-releasing hormone pulse generator to KATP channel modulation.
    Huang W; Acosta-Martínez M; Levine JE
    Endocrinology; 2008 May; 149(5):2423-32. PubMed ID: 18258681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two neonatal diabetes mutations on transmembrane helix 15 of SUR1 increase affinity for ATP and ADP at nucleotide binding domain 2.
    Ortiz D; Voyvodic P; Gossack L; Quast U; Bryan J
    J Biol Chem; 2012 May; 287(22):17985-95. PubMed ID: 22451668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered interaction between SUR1 and Kir6.2 that enhances ATP sensitivity in KATP channels.
    Pratt EB; Zhou Q; Gay JW; Shyng SL
    J Gen Physiol; 2012 Aug; 140(2):175-87. PubMed ID: 22802363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasting-induced suppression of LH secretion does not require activation of ATP-sensitive potassium channels.
    Huang W; Acosta-Martínez M; Horton TH; Levine JE
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1439-46. PubMed ID: 18840760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal diabetes caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels.
    Zhou Q; Garin I; Castaño L; Argente J; Muñoz-Calvo MT; Perez de Nanclares G; Shyng SL
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E473-8. PubMed ID: 20810569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the K(ATP) channel by Mg-nucleotide interaction with SUR1.
    Proks P; de Wet H; Ashcroft FM
    J Gen Physiol; 2010 Oct; 136(4):389-405. PubMed ID: 20876358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
    Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
    J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
    Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
    Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.
    Hambrock A; Löffler-Walz C; Quast U
    Br J Pharmacol; 2002 Aug; 136(7):995-1004. PubMed ID: 12145099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New ABCC8 mutations in relapsing neonatal diabetes and clinical features.
    Vaxillaire M; Dechaume A; Busiah K; Cavé H; Pereira S; Scharfmann R; de Nanclares GP; Castano L; Froguel P; Polak M;
    Diabetes; 2007 Jun; 56(6):1737-41. PubMed ID: 17389331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells.
    Nenquin M; Szollosi A; Aguilar-Bryan L; Bryan J; Henquin JC
    J Biol Chem; 2004 Jul; 279(31):32316-24. PubMed ID: 15175349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H3 domain of syntaxin 1A inhibits KATP channels by its actions on the sulfonylurea receptor 1 nucleotide-binding folds-1 and -2.
    Cui N; Kang Y; He Y; Leung YM; Xie H; Pasyk EA; Gao X; Sheu L; Hansen JB; Wahl P; Tsushima RG; Gaisano HY
    J Biol Chem; 2004 Dec; 279(51):53259-65. PubMed ID: 15485808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Function and distribution of the SUR isoforms and splice variants.
    Shi NQ; Ye B; Makielski JC
    J Mol Cell Cardiol; 2005 Jul; 39(1):51-60. PubMed ID: 15978902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels.
    Wheeler A; Wang C; Yang K; Fang K; Davis K; Styer AM; Mirshahi U; Moreau C; Revilloud J; Vivaudou M; Liu S; Mirshahi T; Chan KW
    Mol Pharmacol; 2008 Nov; 74(5):1333-44. PubMed ID: 18723823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
    Winkler M; Lutz R; Russ U; Quast U; Bryan J
    J Biol Chem; 2009 Mar; 284(11):6752-62. PubMed ID: 19139106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin secretagogues, sulfonylurea receptors and K(ATP) channels.
    Bryan J; Crane A; Vila-Carriles WH; Babenko AP; Aguilar-Bryan L
    Curr Pharm Des; 2005; 11(21):2699-716. PubMed ID: 16101450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP.
    Jin JY; Park SH; Bae JH; Cho HC; Lim JG; Park WS; Han J; Lee JH; Song DK
    Pharmacol Res; 2007 Sep; 56(3):237-47. PubMed ID: 17656102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.